ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $501,000 | +54.6% | 169,369 | -17.0% | 0.05% | +37.8% |
| Q4 2018 | $324,000 | -66.0% | 203,969 | -21.3% | 0.04% | -30.2% |
| Q3 2018 | $954,000 | +38.5% | 259,169 | +6.5% | 0.05% | +55.9% |
| Q2 2018 | $689,000 | +79.9% | 243,369 | +82.9% | 0.03% | +47.8% |
| Q4 2017 | $383,000 | -73.1% | 133,058 | -58.0% | 0.02% | -76.3% |
| Q3 2017 | $1,423,000 | -20.0% | 316,900 | -18.2% | 0.10% | -16.4% |
| Q2 2017 | $1,778,000 | +52.1% | 387,258 | +39.5% | 0.12% | +84.1% |
| Q1 2017 | $1,169,000 | +34.1% | 277,700 | +31.6% | 0.06% | +21.2% |
| Q4 2016 | $872,000 | +160.3% | 211,027 | +410.4% | 0.05% | +188.9% |
| Q3 2016 | $335,000 | +280.7% | 41,348 | +266.0% | 0.02% | +260.0% |
| Q2 2016 | $88,000 | -30.7% | 11,298 | -12.6% | 0.01% | 0.0% |
| Q1 2015 | $127,000 | – | 12,927 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |